Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Gastric antimicrobial peptides fail to eradicate Helicobacter pylori infection due to selective induction and resistance.

Nuding S, Gersemann M, Hosaka Y, Konietzny S, Schaefer C, Beisner J, Schroeder BO, Ostaff MJ, Saigenji K, Ott G, Schaller M, Stange EF, Wehkamp J.

PLoS One. 2013 Sep 11;8(9):e73867. doi: 10.1371/journal.pone.0073867. eCollection 2013.

2.

Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis.

Bajaj-Elliott M, Fedeli P, Smith GV, Domizio P, Maher L, Ali RS, Quinn AG, Farthing MJ.

Gut. 2002 Sep;51(3):356-61.

3.

Expression of beta-defensin 4 is increased in human gastritis.

Otte JM, Neumann HM, Brand S, Schrader H, Schmidt WE, Schmitz F.

Eur J Clin Invest. 2009 Feb;39(2):126-38. doi: 10.1111/j.1365-2362.2008.02071.x.

PMID:
19200166
4.

Differential expression of human beta defensin 2 and 3 in gastric mucosa of Helicobacter pylori-infected individuals.

Bauer B, Wex T, Kuester D, Meyer T, Malfertheiner P.

Helicobacter. 2013 Feb;18(1):6-12. doi: 10.1111/hel.12000. Epub 2012 Aug 28. Review.

PMID:
23067102
5.

Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status.

Wehkamp J, Schmidt K, Herrlinger KR, Baxmann S, Behling S, Wohlschläger C, Feller AC, Stange EF, Fellermann K.

J Clin Pathol. 2003 May;56(5):352-7.

6.

Antimicrobial host defense in the upper gastrointestinal tract.

Hosaka Y, Koslowski M, Nuding S, Wang G, Schlee M, Schäfer C, Saigenji K, Stange EF, Wehkamp J.

Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1151-8. doi: 10.1097/MEG.0b013e3283052ddb.

PMID:
18989140
7.

Human beta-defensin-3 induction in H. pylori-infected gastric mucosal tissues.

Kawauchi K, Yagihashi A, Tsuji N, Uehara N, Furuya D, Kobayashi D, Watanabe N.

World J Gastroenterol. 2006 Sep 28;12(36):5793-7.

8.

Effects of cagA+ and cagA- strains of Helicobacter pylori on the human gastric mucus layer thickness.

Al-Marhoon MS, Nunn S, Soames RW.

J Gastroenterol Hepatol. 2005 Aug;20(8):1246-52.

PMID:
16048574
9.

Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection.

Boughan PK, Argent RH, Body-Malapel M, Park JH, Ewings KE, Bowie AG, Ong SJ, Cook SJ, Sorensen OE, Manzo BA, Inohara N, Klein NJ, Nuñez G, Atherton JC, Bajaj-Elliott M.

J Biol Chem. 2006 Apr 28;281(17):11637-48. Epub 2006 Mar 2.

10.

Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.

Jorge O, Cuello Carrión FD, Jorge A, Ciocca DR.

Rev Esp Enferm Dig. 2003 Feb;95(2):97-104, 89-96. English, Spanish.

PMID:
12760717
11.

Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori.

Hamanaka Y, Nakashima M, Wada A, Ito M, Kurazono H, Hojo H, Nakahara Y, Kohno S, Hirayama T, Sekine I.

Gut. 2001 Oct;49(4):481-7.

12.

Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.

McGuckin MA, Every AL, Skene CD, Linden SK, Chionh YT, Swierczak A, McAuley J, Harbour S, Kaparakis M, Ferrero R, Sutton P.

Gastroenterology. 2007 Oct;133(4):1210-8. Epub 2007 Jul 10.

PMID:
17919495
13.

Helicobacter pylori induces promoter hypermethylation and downregulates gene expression of IRX1 transcription factor on human gastric mucosa.

Guo XB, Guo L, Zhi QM, Ji J, Jiang JL, Zhang RJ, Zhang JN, Zhang J, Chen XH, Cai Q, Li JF, Yan M, Gu QL, Liu BY, Zhu ZG, Yu YY.

J Gastroenterol Hepatol. 2011 Nov;26(11):1685-90. doi: 10.1111/j.1440-1746.2011.06808.x.

PMID:
21649733
14.

Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner.

Hornsby MJ, Huff JL, Kays RJ, Canfield DR, Bevins CL, Solnick JV.

Gastroenterology. 2008 Apr;134(4):1049-57. doi: 10.1053/j.gastro.2008.01.018. Epub 2008 Jan 11.

15.

Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes.

Midorikawa K, Ouhara K, Komatsuzawa H, Kawai T, Yamada S, Fujiwara T, Yamazaki K, Sayama K, Taubman MA, Kurihara H, Hashimoto K, Sugai M.

Infect Immun. 2003 Jul;71(7):3730-9.

16.

[Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].

Unger Z, Prónai L, Szaleczky E, Zágoni T, Molnár B, Tulassay Z.

Orv Hetil. 2000 Dec 10;141(50):2695-700. Hungarian.

PMID:
11189675
17.

Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori.

Hase K, Murakami M, Iimura M, Cole SP, Horibe Y, Ohtake T, Obonyo M, Gallo RL, Eckmann L, Kagnoff MF.

Gastroenterology. 2003 Dec;125(6):1613-25.

PMID:
14724813
18.

Potential role of human beta-defensin 1 in Helicobacter pylori-induced gastritis.

Kocsis AK, Kiss ZF, Tiszlavicz L, Tiszlavicz Z, Mándi Y.

Scand J Gastroenterol. 2009;44(3):289-95. doi: 10.1080/00365520802530879.

PMID:
18991164
19.

Decreased expression of epidermal growth factor receptor and mRNA of its ligands in Helicobacter pylori-infected gastric mucosa.

Schiemann U, Konturek JW, Osterhoff M, Assert R, Rembiasz K, Pfeiffer D, Schatz H, Domschke W, Pfeiffer A.

Scand J Gastroenterol. 2001 Jan;36(1):23-31.

PMID:
11218236
20.

Supplemental Content

Support Center